Biotechnology is one of the fastest growing industries in the world offering revolutionary solutions to some of the most pressing challenges of our time.
1.55
USD Trillion
The global biotechnology market was valued at USD 1.55 trillion in 2023.
13.96
%
CAGR 2024 - 2030
The projected compound annual growth rate (CAGR) is 13.96% from 2024 to 2030.
Finnish Bioindustries participates in national and international technology programs to commercialise and promote new areas of biotechnology.
Being a technology-intensive industry, many of the biotechnology issues concern international research and technological development. Finnish Bioindustries is a national member of EuropaBio (European Association for Biotechnology), which was founded in 1996 to promote the European biotechnology industry. FIB is also a member of the US-based BIO (Biotechnology Industry Organisation) and the Australian AusBiotech.
The biotechnology sector is one of the most innovative industries in the European Union EU, with almost 7,300 patent applications.
Finnish companies have a vital role in this developments.
823.5
USD Billion
The global biotechnology market was valued at USD 823.5 billion in 2021.
9.4
%
CAGR 2022 - 2030
The projected compound annual growth rate (CAGR) is 9.4% from 2022 to 2030.
For updates and News
For more information
Alexandra Peth
Managing Director
Finnish Bioindustries FIB
Eteläranta 10, FI-00131 Helsinki
Board of Directors
With a commitment to excellence, innovation, and corporate governance, our Board of Directors plays a pivotal role in steering FIB towards sustainable growth and success.
Maarit Merla
Kansallinen Lääkekehityskeskus Oy
Chair
Mari Björkman
Helsinki Innovation Services (HIS)
Marco Hautalahti
Finnish Biobank Cooperative FINBB
Kaisa Helminen
Aiforia Technologies Oy
Tarja Hirvensalo
Medix Biochemica Oy
Lotte Bruns
Orion Oyj
Antti Nieminen
Biovian Oy
Lasse Leino
DelSiTech Oy
Sara Kangaspeska
Innovestor Life Science Oy
Pekka Kekki
Roal Oy